Skip to main content
. 2023 Mar 13;2023(3):CD010941. doi: 10.1002/14651858.CD010941.pub3

4.24. Analysis.

4.24

Comparison 4: Individual tailored versus continuous tapered dexamethasone regimen, Outcome 24: Death or abnormal neurodevelopmental outcome (various definitions)